Risk factor
Negligible price volatility
Profitability factor
Strong growth
About
Otsuka Holdings Co., Ltd. engages in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of oncology, cardiovascular system, renal system, digestive system, ophthalmology, diagnostics, and intravenous solutions, as well as medical devices businesses. It also provides EQUELLE, a product for women's health and beauty; BODYMAINTÉ Jelly, a...
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITDA, tradin
Target Price
The average target price of 4578.T is 9364 and suggests 1% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell